[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. --------------------------------------------------------------- [Is This "Military Tech Crisis" About To Spark A $15B Boom For Investors?](=) [While Also Sparking A Potential Boom In 2022. (Read This Special Report to See What It Is)]() --------------------------------------------------------------- July 26, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [WARNING: White House Declares "National Lithium Emergency"]() With the US dependent on China for the most critical resource we use for our military, electric vehicles and power grid... The US is facing a "National Lithium Emergency". They are pumping hundreds of millions into sparking our lithium production. And one, domestic Lithium exploration company just staked 11,700 acres of mineral claims in Nevada... [Read This Report To See Why Investors Are So Excited About These 11,700 Acres of Mineral Claims]() --------------------------------------------------------------- [Talaris Therapeutics, TALS](=) Recent Analyst Action: Mani Foroohar, analyst at SVB Securities, reiterates coverage on [Talaris Therapeutics (TALS)](in the Healthcare sector with a Hold rating and a price target of $7 (1 week ago). - Recent Price: $4.89 - Average Analyst Price Target: $8.67 (77.30%) - Market Cap: $162.54M [TipRanks.com](=) also reports that [Talaris Therapeutics](=)currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $8.67. The target pricing ranges from a high forecast of $11.00 down to a low forecast of $7.00. [Talaris Therapeutics (TALS)](’s last closing price was $4.89 which would put the average price target at $8.67. Here are 3rd party ratings for [TALS](=): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Top 34% (85 out of 252) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- [Is Apple Pointing to a Massive Recession in the U.S.?](=) Apple (AAPL) is making moves behind the scenes to prepare for a downturn… Bloomberg recently reported that the tech giant plans to freeze hiring in some divisions- while remaining cautious on spending through next year. And the thing is, Apple isn’t alone…[Bottom-line: Apple might be pointing to a massive recession in the U.S.](=) If you have any serious assets in the market, there is [one critical step you must take now.]( = --------------------------------------------------------------- [General Electric, GE]() Recent Analyst Action: Stephen Tusa, analyst at J.P. Morgan, reiterates coverage on [General Electric (GE)]()in the Industrial Goods sector with a Hold rating (1 day ago). - Recent Price: $73.13 - Average Analyst Price Target: $91.22 (24.74%) - Market Cap: $75.24B [TipRanks.com](=) also reports that [General Electric](currently has 11 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $91.22. The target pricing ranges from a high forecast of $113.00 down to a low forecast of $72.00. [General Electric (GE)]()’s last closing price was $73.13 which would put the average price target at $91.22. Here are 3rd party ratings for [GE](): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Sell, Bottom 48% (132 out of 252) [Click here for chart >>]() -------------------------------------------------------------------------- [Synaptogenix, SNPX]() Recent Analyst Action: Jason McCarthy, analyst at Maxim Group, reiterates coverage on [Synaptogenix (SNPX)](=)in the Healthcare sector with a Buy rating and a price target of $14 (6 days ago). - Recent Price: $5.4 - Average Analyst Price Target: $14.00 (159.26%) - Market Cap: $34.70M [TipRanks.com](=) also reports that [Synaptogenix]()currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $14.00. The target pricing ranges from a high forecast of $14.00 down to a low forecast of $14.00. [Synaptogenix (SNPX)]()’s last closing price was $5.4 which would put the average price target at $14.00. Here are 3rd party ratings for [SNPX](): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: n/a, n/a [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- [Gas stations giving up gasoline](=) The government is pushing oil and gas companies to switch over their fueling stations… The goal is 500,000 stations nationwide. [Here’s how it’s going to play out.]() --------------------------------------------------------------- [Alvotech, ALVO](=) Recent Analyst Action: Andrew Baum, analyst at Citigroup, reiterates coverage on [Alvotech (ALVO)]()in the Healthcare sector with a Buy rating and a price target of $12 (13 hours ago). - Recent Price: $7.92 - Average Analyst Price Target: $16.25 (105.18%) - Market Cap: $1.89B [TipRanks.com](=) also reports that [Alvotech](=)currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $16.25. The target pricing ranges from a high forecast of $22.00 down to a low forecast of $10.00. [Alvotech (ALVO)]()’s last closing price was $7.92 which would put the average price target at $16.25. Here are 3rd party ratings for [ALVO](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: n/a - Zacks.com: Buy, Top 29% (72 out of 252) [Click here for chart >>]() -------------------------------------------------------------------------- [Alexandria Equities, ARE]( Recent Analyst Action: Unknown Analyst, analyst at Citigroup, reiterates coverage on [Alexandria Equities (ARE)](in the Financial sector with a Buy rating and a price target of $180 (2 weeks ago). - Recent Price: $155.95 - Average Analyst Price Target: $195.00 (25.04%) - Market Cap: $24.53B [TipRanks.com](=) also reports that [Alexandria Equities]()currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $195.00. The target pricing ranges from a high forecast of $230.00 down to a low forecast of $140.00. [Alexandria Equities (ARE)](’s last closing price was $155.95 which would put the average price target at $195.00. Here are 3rd party ratings for [ARE](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 33% (83 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [FDR did it first; Biden plans much worse...](=) April 5, 1933, President Roosevelt signed Executive Order 6102 — changing the U.S. dollar forever… On March 9, 2022, President Biden signed Executive Order 14067 — which could change the dollar again, into something much worse… [Go here now to see the potentially sinister outcome of Biden’s new executive order.](=) = --------------------------------------------------------------- [Semler Scientific, SMLR](=) Recent Analyst Action: Marc Wiesenberger, analyst at B.Riley Financial, reiterates coverage on [Semler Scientific (SMLR)](in the Healthcare sector with a Buy rating and a price target of $60 (2 months ago). - Recent Price: $29.6 - Average Analyst Price Target: $60.00 (102.70%) - Market Cap: $194.36M [TipRanks.com](=) also reports that [Semler Scientific](=)currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $60.00. The target pricing ranges from a high forecast of $60.00 down to a low forecast of $60.00. [Semler Scientific (SMLR)](=)’s last closing price was $29.6 which would put the average price target at $60.00. Here are 3rd party ratings for [SMLR](=): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 32% (81 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Oak Street Health, OSH]( Recent Analyst Action: Kevin Fischbeck, analyst at Bank of America Securities, reiterates coverage on [Oak Street Health (OSH)](=)in the Healthcare sector with a Sell rating and a price target of $18 (1 month ago). - Recent Price: $28.56 - Average Analyst Price Target: $26.78 (-6.23%) - Market Cap: $6.69B [TipRanks.com](=) also reports that [Oak Street Health](currently has 10 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $26.78. The target pricing ranges from a high forecast of $33.00 down to a low forecast of $18.00. [Oak Street Health (OSH)](’s last closing price was $28.56 which would put the average price target at $26.78. Here are 3rd party ratings for [OSH](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Bottom 44% (140 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Which State Is Ranked #1 For Lithium Investors?]() The Fraser Institute ran a survey to find the best spot in the world for lithium mining. They researched 77 spots from around the world… and the Nevada Desert won the #1 spot by a landslide. And this small mining company just staked 11,700 acres of mineral claims in Nevada's hottest lithium spot... [Click Here To See Why This Lithium Stock Could Explode](=) --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. Sincerely, Editor, MarketSectorDaily.com [Unsubscribe](=) Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954